Randhawa Simrat Insider Trades

Insider Trading History

Track insider trading activity for Randhawa Simrat. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $9.81M 96,875 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.37M 26,530 shares
$89.45
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $3.09M 30,530 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.37M 26,530 shares
$89.45
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $2.54M 25,102 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.4M 26,530 shares
$90.62
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $0 0 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.76M 33,830 shares
$81.48
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $3.43M 33,830 shares
Last Trade
Mar 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 33,830 shares
$80.32
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $10.8M 106,250 shares
Last Trade
Mar 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 33,830 shares
$80.32
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $15.2M 150,000 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.87M 150,000 shares
$52.46
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $405k 4,000 shares
Last Trade
Nov 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.16M 109,031 shares
$38.14
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $12M 118,750 shares
Last Trade
Nov 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.45M 109,031 shares
$40.85
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $11.4M 113,031 shares
Last Trade
Nov 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.45M 109,031 shares
$40.85
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $9.27M 91,507 shares
Last Trade
Nov 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.11M 87,507 shares
$35.50
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $6.62M 65,341 shares
Last Trade
Nov 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.22M 87,507 shares
$36.81
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $11.8M 116,471 shares
Last Trade
Nov 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.11M 87,507 shares
$35.50
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF MEDICAL OFFICER
Holding Value $6.08M 60,000 shares
Last Trade
Sep 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.27M 60,000 shares
$37.87
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF MEDICAL OFFICER
Holding Value $15.2M 150,000 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.31M 150,000 shares
$22.07
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF MEDICAL OFFICER
Holding Value $10.1M 100,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.18M 100,000 shares
$21.77
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF MEDICAL OFFICER
Holding Value $12.2M 120,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.15M 120,000 shares
$17.88
$101.28
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Medical Officer
Holding Value $405k 4,000 shares
Last Trade
Sep 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.4k 2,000 shares
$13.20
$101.28
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Medical Officer
Holding Value $2.8k 4,000 shares
Last Trade
Sep 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.4k 2,000 shares
$0.70
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Medical Officer
Holding Value $203k 2,000 shares
Last Trade
Sep 21, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.4k 2,000 shares
$13.20
$101.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up